Ad
related to: covid-19
Search results
Opinion: Lawmakers must champion AI-powered medical innovations
The Gazette· 3 hours agoThe COVID-19 pandemic highlighted the pressing need for medical innovations to improve public health...
Column: Is our flag at half staff all the time now? For Memorial Day, we asked why
Chicago Tribune· 2 hours agoThis Memorial Day, assuming you wake up early enough, you may notice the United States flag at half...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
EDITORIAL: Maine tourism can complete 'pandemic rebound' in 2024
Portland Press Herald, Maine via Yahoo Finance· 4 hours agoMay 26—Since the COVID-19 pandemic ripped around the globe, forcing people to stay at home, cutting off traditional outlets for expenditure and creating ...
Trump confronts repeated booing during Libertarian convention speech
KTEP 88.5 El Paso· 8 hours agoDonald Trump was booed repeatedly while addressing the Libertarian Party National Convention on...
Texas lawmakers again try to prohibit private businesses from requiring COVID-19 vaccines
KRGV Rio Grande Valley· 15 hours agoTexas Tribune’s daily newsletter that keeps readers up to speed on the most essential Texas news....
Metro High student persists over obstacles, earns diploma
The Gazette· 2 hours agoPartee, 18, struggled to learn online during her freshman year at Kennedy High School in the fall of...
Trump booed, heckled by crowd at Libertarian convention - BusinessWorld Online
BusinessWorld· 2 hours agoLibertarians, who believe in limited government and individual freedom, blame Mr. Trump, a...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 1 hour agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...